Explaining Brazil #119: Brazil’s place in the race for a Covid-19 vaccine

Ironically, Brazil's mismanagement of the coronavirus crisis may lead to the country cutting the line in the race for a vaccine

This week’s episode, Brazil’s place in the race for a Covid-19 vaccine, was supported by AMEC, the Brazilian Association of Investors in Capital Markets. AMEC brings together around 60 institutional investors from Brazil and abroad — which have a combined portfolio of over USD 130 billion. AMEC works to support minority shareholders’ rights by fostering governance and stewardship principles that strengthen the market as a whole.

Brazil has miserably failed in its half-hearted attempt to contain the coronavirus. In five months, the country recorded almost 3 million infections and nearly 100 thousand deaths. And the spread of the disease shows no signs of slowing down. Ironically, however, the fact that the coronavirus spread is still active in Brazil means that it could well become the first country in the world to receive a Covid-19 vaccine.

Listen and subscribe to our podcast from your mobile device:

Spotify | Apple Podcasts | Google Podcasts | Deezer

On this episode:

  • Fernando Spilki is the president of the Brazilian Society for Virology. He coordinates a Brazilian effort to map the genome of the Sars-CoV-2 virus, which causes Covid-19. Dr. Spilki is also a member of the Advisory Board at the U.S.-based organization Dimensions Sciences, which fosters scientific research in Brazil. 

Background reading on the Covid-19 vaccine:

Do you have a suggestion for our next Explaining Brazil podcast? Drop us a line at [email protected]

Don’t forget to follow us on Twitter and Facebook.

Support this coverage →Support this podcast →